Tuberculosis (TB) poses formidable challenges to global health at the public health, scientific and political level. The current tools to combat TB are out of the date and not accurate enough to identify many TB infections. Though recent and ongoing advancements in drug therapies offer great promise for saving lives, the unfortunate fact is that they are drug resistant to both first and second line anti-TB medicines. The key challenge in the fight against TB is to innovate and adapt promising innovations to achieve protection and eradication. Making faster and more accurate diagnosis, and effective treatment and widespread use in the developing world where they are needed most, will vastly reduce TB cases worldwide and save millions of lives. New international efforts have now started to address move against TB which is the theme for World TB Day 2011–12. This article attempts to examine the steps on the move against tuberculosis in terms of safe and reliable prevention, development of new tools for diagnosis and drugs for treatment, access of quality care and community outreach activities.
AgrawalD.UdwadiaZ.F.RodriguezC.MehtaA. (2009). Increasing incidence of fluoroquinolone-resistant Mycobacterium tuberculosis in Mumbai, India. International Journal of Tuberculosis and Lung Disease, 13, 79–83.
2.
AhmadR.A.MahendradhataYodiCunninghamJaneUtariniAdiVlasSake J. de (2009). How to optimize tuberculosis case finding: Explorations for Indonesia with a health system model. BMC Infectious Diseases, 9: 87 doi:10.1186/1471-2334-9-87.
3.
BalasubramanianR.RajeswariR.VijayabhaskaraR.D.JaggarajammaK.GopiP.G.ChandrasekaranV.NarayananP.R. (2006). A rural public-private partnership model in tuberculosis control in South India. International Journal of Tuberculosis and Lung Disease, 10(12), 1380–85.
4.
BasuS.AndrewsJ.PoolmanE.M.. (2007). The impact of preventing nosocomial transmission of extensively drug-resistant (XDR) tuberculosis in rural South African district hospitals. The Lancet, 370, 1500–07.
5.
DatikoD.G.LindtjørnB. (2009). Health extension workers improve tuberculosis case detection and treatment success in Southern Ethiopia: A community randomized trial. PLoS ONE, 4(5), e5443. doi:10.1371/journal.pone.0005443.
6.
Foundation for Innovative New Diagnostics. Why new tools are needed to fight poverty related infectious diseases. http://www.finddiagnostics.org
GandhiN.R.MollA.SturmA.W.. (2006). Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet, 368, 1575–80.
9.
Ginsberg, A.M. Drugs in Development for Tuberculosis. (2010). Drugs, 70(17), 2201–14.
10.
GopiP.G.SubramaniR.SadacharamK.NarayananP.R. (2006). Yield of pulmonary tuberculosis cases by employing two screening methods in a community survey. International Journal of Tuberculosis and Lung Disease, 10(3), 343–45.
11.
HellerR.F.GemmellI.EdwardsR.BuchanI.AwasthiS.VolminkJ.A. (2006). Prioritising between direct observation of therapy and case finding interventions for tuberculosis: use of population impact measures. BMC Medicine, 4, 35.
12.
KolappanC.GopiP.G.SubramaniR.NarayananP.R. (2007). Selected biological and behavioural risk factors associated with pulmonary tuberculosis. International Journal of Tuberculosis and Lung Disease, 11(9), 999–1003.
13.
MuniyandiM.RajeswariR.BalasubramanianR.NarayanaP.R. (2008). A Comparison of costs to patients with tuberculosis treated in a DOTS programme with those in a non-DOTS programme in South India. Journal of Health Management, 10(1), 9–24.
14.
MuniyandiM.RamachandranR.GopiP.G.ChandrasekaranV.SubramaniR.SadacharamK.KumaranP.SanthaT.WaresF.NarayananP.R. (2007). The prevalence of tuberculosis in different economic strata: A community survey from South India. International Journal of Tuberculosis and Lung Disease, 11(9), 1042–45.
15.
ParamasivanC.N.RehmanF.WaresF.Sundar MohanN.SundarS.DeviS.NarayananP.R. (2010). First- and second-line drug resistance patterns among previously treated tuberculosis patients in India. International Journal of Tuberculosis and Lung Disease, 14(2), 243–46.
RajeswariR.ChandrasekaranV.SuhadevM.SivasubramaniamS.SudhaG.RenuG. (2002). Factors associated with patient and health system delays in the diagnosis of tuberculosis in South India. International Journal of Tuberculosis and Lung Diseases, 6(9), 789–95.
18.
SanthaT.RenuGargFriedenT.R.SubramaniR.GopiP.G.ChandrasekaranV.SelvakumarN.ThomasA.RajeswariR.BalasubramanianR.KolappanC.NarayananP.R. (2003). Are community surveys to detect tuberculosis in high prevalence areas useful? Results of a comparative study from Tiruvallur District, South India. International Journal of Tuberculosis and Lung Disease, 7(3), 258–65.
SlamaK.ChiangC.Y.EnarsonD.A.HassmillerK.FanningA.GuptaP.RayC. (2007). Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. International Journal of Tuberculosis and Lung Disease, 11(10), 1049–61.
21.
The National Institute of Allergy and Infectious Diseases (2007). Research agenda: Multidrug-resistant and extensively drug-resistant tuberculosis. NIAID Tuberculosis Working Group.
22.
TangcharoensathienV.Walaiporn PatcharanarumolI.PorIrAljunidSyed MohamedMuktiAli GhufronAkkhavongKongsapBanzonEduardoHuongDang BoiThabranyHasbullahMillsAnne (2011). Health-financing reforms in Southeast Asia: Challenges in achieving universal coverage. The Lancet, 377: 863–73.
23.
Tuberculosis Coalition for Technical Assistance (2006). International Standards for Tuberculosis Care (ISTC). The Hague: Tuberculosis Coalition for Technical Assistance.
24.
WagstaffA. (2007). Social health insurance reexamined (January2007). World Bank Policy Research Working Paper No. 4111.
25.
World Health Organization (WHO) (2002). An expanded DOTS framework for effective tuberculosis control. Geneva: World Health Organization. WHO/CDS/TB/2002.297
26.
World Health Organization (WHO). Global plan to stop TB 2006-2015: Part-I: strategic directions. WHO, Stop TB Partnership.
